Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFRSF4/OX40/CD134 Antibody (Tavolixizumab)

Catalog No.
F1480
Anti-TNFRSF4/OX40/CD134 Antibody (Tavolixizumab)
Grouped product items
SizePriceStock Qty
100ug
$75.00
Ship with 3-5 days
1mg
$225.00
Ship with 3-5 days
5mg
$630.00
Ship with 3-5 days
50mg
$2,111.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Tavolixizumab (MEDI 0562; Tavolimab) is a humanized TNFRSF4 (TNF receptor superfamily member 4) monoclonal antibody for cancer immunology research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

146.36 kDa

Shipping

Dry ice

Cas No.

1635395-25-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

MEDI0562, MEDI-0562, tavolimab

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P43489

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human CD134 His at 2 ug/mL can bind Anti-TNFRSF4/OX40/CD134 Antibody (Tavolixizumab)

Target

TNFRSF4 / OX40 / CD134

Note

Please avoid freeze-thaw cycles.